<DOC>
	<DOCNO>NCT01671072</DOCNO>
	<brief_summary>The purpose study determine whether TissueGene-C , allogeneic human chondrocytes express Transforming Growth Factor ( TGF ) -b1 , effective safe patient degenerative arthritis</brief_summary>
	<brief_title>Efficacy Safety Study TissueGene-C Degenerative Arthritis</brief_title>
	<detailed_description>TissueGene-C biological new drug consist normal chondrocytes transduce chondrocytes express growth factor regenerate damage cartilage tissue . In clinical trial Phase 2b , investigator compare TissueGene-C placebo 6 - month trial 54 outpatient degenerative arthritis . The outpatient assign TissueGene-C placebo 1:1 ratio , monitor record improve clinical symptom , sport activity , function knee , presence adverse event .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>1 . Female male age 18 year 2 . Diagnosed degenerative arthritis knee 3 . With IKDC score 60 low screen visit 4 . With Grade 2 3 osteoarthritis determine radiographic criterion Kellgren Lawrence 5 . With Body Mass Index ( BMI ) high than18.5 lower 30 6 . With International Cartilage Repair Society ( ICRS ) Grade IV cartilage damage major lesion , confirm MRI scan 7 . With major lesion concentrate one section knee , major lesion consider main cause clinical symptom 8 . With alleviation symptom even least three month nonsurgical treatment 9 . Healthy , major finding physical examination , hematology , serum chemistry , urine test , significant medical history 10 . Agreed use effective contraceptive method study period 11 . Voluntarily agree participate study , sign informed consent form 1 . Showed clinically significant hematology , serum chemistry , urine test result screen visit 2 . Falls Inclusion Criteria 6 damage relevant lesion consider ICRS Grade IV size 6 cm2 3 . Took glucosamine , chondroitin , natural medicine within 14 day injection investigational product ( 14day washout period elapse , patient enrol study ) 4 . Has take antiinflammatory drug ( prescribe overthecounter ) within 14 day injection investigational product ( 14day washout period elapse , patient enrol study ) 5 . Has take immunosuppressive agent , include antirheumatic drug ( e.g. , methotrexate antimetabolite ) within 3 month enrollment study 6 . With history drug abuse within one year prior enrollment study , show positive result urine drug test serum alcohol test screen visit 7 . Received injection target knee within two month enrollment study 8 . Pregnant breastfeed female 9 . With another joint disease apart degenerative arthritis ( e.g. , systemic rheumatic inflammatory disease associate knee chondrocalcinosis , hemachromatosis , inflammatory arthritis , necrosis trochanter , Paget 's disease adjacent joint femur tibia , ochronosis , hemophilic arthropathy , infectious arthritis , Charcot 's disease knee joint , villonodular synovitis , synovial chondroma ) 10 . With infectious disease , include HIV hepatitis 11 . With follow clinically significant disease : heart disease [ e.g. , myocardial infarction , arrhythmia , serious heart disease , coronary artery bypass graft ( CABG ) ] kidney disease ( e.g. , chronic renal failure , glomerulonephritis ) liver disease ( e.g. , liver cirrhosis , fatty liver , acute chronic liver disease ) endocrine disease ( e.g. , hyperthyroidism , hypothyroidism , thyroiditis , diabetes insipidus , Cushing 's disease ) insulindependent diabetes mellitus medical history past current malignant tumor In particular , tumor TissueGeneC may aggravate screen use follow test : Leukemia ( White Blood Cell level hematology ) Osteochondroma , Chondromas , Chondroblastoma , Chondromyxoid fibroma , Chondrosarcoma ( Alkaline phosphatase level hematology ) 12 . Participated another clinical trial ( use investigational drug medical device ) within 30 day enrollment study 13 . Considered inappropriate investigator participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Chondrocyte cell</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Gene therapy</keyword>
</DOC>